Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000233437 | SCV000290092 | benign | Alstrom syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000428195 | SCV000524247 | benign | not specified | 2016-12-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Personalized Diabetes Medicine Program, |
RCV000445537 | SCV000536973 | benign | Monogenic diabetes | 2019-02-15 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL 0.049 + 6 predictors; not using PP3 (2 predictors)), BP1 (missense when truncating cause ds), BS2 (18 homozygotes in gnomAD), BA1 (3.4% MAF in gnomAD African): Benign ( ALMS1 p.P2184S and p.K1810N are likely in LD) |
Laboratory for Molecular Medicine, |
RCV000428195 | SCV000711811 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Lys1810Asn in exon 8 of ALMS1: This variant is not expected to have clinical s ignificance because it has been identified in 3.30% (320/9702) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs78039319). |
ARUP Laboratories, |
RCV000233437 | SCV002506092 | benign | Alstrom syndrome | 2022-02-08 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV000233437 | SCV002605255 | uncertain significance | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs78039319 in Alstrom syndrome yet. | |
Ambry Genetics | RCV002347903 | SCV002648028 | benign | Cardiovascular phenotype | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000233437 | SCV001463048 | benign | Alstrom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000428195 | SCV002034140 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795371 | SCV002036999 | likely benign | not provided | no assertion criteria provided | clinical testing |